AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Gamida Cell Announces the Date of Its Third Quarter 2019 Financial Results and Webcast

November 5, 2019

BOSTON--(BUSINESS WIRE)--Nov 5, 2019--

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the company will host a conference call and live audio webcast on Wednesday, November 13, 2019, at 4:30 p.m. ET to review its third quarter 2019 financial results and provide an update on the company.

The webcast will be available on the “Investors” section of the Gamida Cell website at www.gamida-cell.com. To participate in the live call, please dial 866-930-5560 (domestic) or 409-216-0605 (international) and refer to conference ID number 8653335. A replay of the webcast will be available approximately two hours after the event, for approximately 30 days.

About Gamida Cell
Gamida Cell is a clinical-stage biopharmaceutical company committed to developing advanced cell therapies with the potential to cure blood cancers and rare, serious hematologic diseases. We are leveraging our proprietary nicotinamide-based, or NAM-based, cell expansion platform to develop product candidates designed to expand the possibility of cell therapy. For additional information, please visit www.gamida-cell.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191105005071/en/

CONTACT: Jaren Irene Madden

jaren@gamida-cell.com

1-617-286-6264

Krystle Gibbs(media)

krystle@tenbridgecommunications.com

508-479-6358

KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL ONCOLOGY

SOURCE: Gamida Cell Ltd.

Copyright Business Wire 2019.

PUB: 11/05/2019 08:31 AM/DISC: 11/05/2019 08:31 AM

http://www.businesswire.com/news/home/20191105005071/en